Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic.
about
Rotavirus vaccine for preventing diarrhoeaPerformance of rotavirus vaccines in developed and developing countriesA cost effective and effective approach to the diagnosis and management of acute infectious diarrheaPrevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines.Global impact of rotavirus vaccines.Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes.Temporal and geographical distributions of human rotavirus serotypes, 1983 to 1988.The role of serum antibodies in the protection against rotavirus disease: an overview.Immune mediators of rotavirus antigenemia clearance in mice.Rotavirus vaccines: an overview.Rotavirus vaccines: update on global impact and future prioritiesAnti-VP6 VHH: An Experimental Treatment for Rotavirus A-Associated DiseaseDifferential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countriesRotavirus infection: a perspective on epidemiology, genomic diversity and vaccine strategies.Human viral gastroenteritis.Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers.Polypeptide composition of rotavirus empty capsids and their possible use as a subunit vaccine.Why does the world need another rotavirus vaccine?Rotavirus-specific cytotoxic T lymphocytes cross-react with target cells infected with different rotavirus serotypes.Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7.Rabbit model of rotavirus infection.Oral rotavirus vaccines: how well will they work where they are needed most?Persistent rotavirus infection in mice with severe combined immunodeficiency.Rotavirus-inhibitory activity in serial milk samples from Mexican women and rotavirus infections in their children during their first year of lifeRotavirus vaccines: how they work or don't work.Relative frequencies of rotavirus serotypes 1, 2, 3, and 4 in Venezuelan infants with gastroenteritisComparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates.Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.Detection of enteropathogens in fatal and potentially fatal diarrhea in Cairo, EgyptBovine milk immunoglobulins for passive immunity to infantile rotavirus gastroenteritis.Protection between different serotypes of bovine rotavirus in gnotobiotic calves: specificity of serum antibody and coproantibody responses.Rotavirus isolate WI61 representing a presumptive new human serotype.Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants.A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix.Four-year study of rotavirus electropherotypes from cases of infantile diarrhea in Rome.Protection of agammaglobulinemic piglets from porcine rotavirus infection by antibody against simian rotavirus SA-11.Epidemiology of rotavirus gastroenteritis.Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period.Efficacy of Two Doses of RIT 4237 Bovine Rotavirus Vaccine for Prevention of Rotavirus Diarrhoea
P2860
Q24247507-36548331-46D4-45B6-AE81-9B862ABA9609Q24600612-48D533B9-958F-432A-B0EE-770220734950Q30443654-AA4D7318-F7FB-4AB9-BF65-9AD2DF07CA0BQ34064371-14F1DD66-4E65-4DCD-8947-AB96902469B5Q34108591-9C9354B4-EFF1-458E-AABD-E714F3D51C4BQ34347258-14043022-E7B7-4559-8683-27FC4CEB90CCQ34456851-A5D38F12-FC60-49A4-926E-C1BBB4CA8118Q34618449-0A7A83F3-FDAA-44AB-90CE-50B8954E7913Q35140279-2977FB28-D91E-49E1-9865-14170C972F0EQ35371774-4CB372AA-C9A8-4FBD-B0DE-FDC609D7FDAFQ35918823-93C1349E-42F6-4F9B-9215-9601195367E6Q36125148-31CAE8C7-C071-49E7-B921-3DBD2EC10A47Q36175693-438A85CE-6614-4982-BCA2-5833592C13B0Q36550022-04A78420-4C81-41CD-AF61-2A250AE5F00FQ36634738-0C719783-26A7-4E5F-8D99-6387ECD89FCBQ36656398-D8539A86-F857-46A4-AFC3-19C34F222B27Q36811869-AC5B311B-0157-4144-915F-3687826722F5Q36822928-417208A1-09AF-4EF8-99AC-B21ED6E0C997Q36825807-5E5750FF-D793-4E7E-991D-B18A141F1716Q36863274-F9BB1AE9-6EFC-4DA0-BD39-881D5D1E06ECQ36866742-1DA75252-7F99-4E21-AE52-5F2B01A667A7Q36903971-A3ED4767-AE44-42EB-8B02-3B4010105543Q36919482-80A1A34F-1252-4314-9AF3-9563353BC323Q37065953-F690C1A6-1986-49F3-8947-1CD99640F740Q37081817-B95927BD-1EAE-4D3F-A231-AD448DCF08B3Q37156618-37C83CEC-164E-45B7-8297-8A1E28EBAE50Q37164301-57CA00A4-334B-4AEC-A013-55C5A0DB9590Q37169945-602B9D0B-7F0A-4C7E-B4C3-18A3745974E6Q37213273-FF43D7D8-0F2D-4F37-8CB8-FC1ED3B8D3A7Q37214333-1BAF8B0D-6D64-47D7-9B2B-8747A890F54FQ37214367-D2956D64-B2F0-4881-B466-B3EE7CC76CCCQ37219186-987179AD-2CB1-4BA7-B734-BCB21475D8C9Q37228110-FAAAF873-9C19-479C-8E66-AC418BC27262Q37547272-BE56147D-5C00-4B04-A703-25FE9ADDC157Q40200060-46C23B81-EBEB-49E8-BC85-CD47F6FFA490Q40212910-352DF6F1-8356-4F73-9C92-CD6ED3C24AAFQ42112614-60F675E3-BF40-4B92-82DB-BCF110657B67Q44284848-92C8D297-D4BA-48C0-A2B9-E9F5244E4864Q56816816-B0F86B24-1C29-4E14-A1E1-38B91A407564
P2860
Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic.
description
1985 nî lūn-bûn
@nan
1985 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Clinical efficacy of the RIT 4 ...... d before a rotavirus epidemic.
@ast
Clinical efficacy of the RIT 4 ...... d before a rotavirus epidemic.
@en
Clinical efficacy of the RIT 4 ...... d before a rotavirus epidemic.
@nl
type
label
Clinical efficacy of the RIT 4 ...... d before a rotavirus epidemic.
@ast
Clinical efficacy of the RIT 4 ...... d before a rotavirus epidemic.
@en
Clinical efficacy of the RIT 4 ...... d before a rotavirus epidemic.
@nl
prefLabel
Clinical efficacy of the RIT 4 ...... d before a rotavirus epidemic.
@ast
Clinical efficacy of the RIT 4 ...... d before a rotavirus epidemic.
@en
Clinical efficacy of the RIT 4 ...... d before a rotavirus epidemic.
@nl
P2093
P1476
Clinical efficacy of the RIT 4 ...... d before a rotavirus epidemic.
@en
P2093
Flewett TH
Isolauri E
Vesikari T
P304
P356
10.1016/S0022-3476(85)80123-2
P407
P577
1985-08-01T00:00:00Z